The aim of the present study was to evaluate sclerotic lesions of the common carotid artery by ultrasonography in 921 in-patients aged 65 years and older (77 ± ± ± ± ± 7 years) and investigate whether lipid levels were associated with carotid atherosclerosis. In men, an increased risk for carotid atherosclerosis was associated with increased levels of low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C). Compared to men with the lowest tertile of LDL-C levels (< 83.4 mg/dl), the adjusted odds ratio was 2.502 (95% confidence interval: 
Introduction
Epidemiologic, clinical, experimental, genetic, and pathological studies have consistently established a primary role for lipoproteins in the development of atherosclerotic vascular disease and subsequent death due to the disease (1) . The National Cholesterol Education Program (1) recommends using the concentration of lowdensity lipoprotein cholesterol (LDL-C) as the gold standard for estimating the lipoprotein related-risk of individuals for complications of atherosclerotic vascular disease, as well as determining the effectiveness of diets or drug. Recently, however, the concentration of non-highdensity lipoprotein cholesterol (non-HDL-C), as distinguished from LDL-C, has been suggested to be a better tool for assessing risk and treatment (2) (3) (4) (5) . The non-HDL-C level is calculated as the difference between total cholesterol (TC) and HDL-C levels and can be determined in any patient regardless of the duration of fasting and the triglyceride (TG) concentration. This method includes all cholesterol present in lipoprotein particles considered to be atherogenic [very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), LDL, and lipoprotein(a)]. However, to our knowledge, few studies have compared the relative usefulness of LDL-C and non-HDL-C levels for the prediction of carotid atherosclerosis in the elderly persons.
Our goal was to determine whether the concentration of non-HDL-C, as well as LDL-C, is an useful predictor of risk for carotid atherosclerosis.
Materials and Methods

Subjects
Participants were enrolled from among in-patients aged 65 years and older treated at the medical department of Nomura Municipal Hospital between August 1999 and April 2004. Patients with severe cardio-renal or nutritional disorders that would affect blood pressure, lipid and glucose metabolism were excluded. All subjects underwent a carotid ultrasound examination for evaluation of possible atherosclerosis. All procedures were approved by the Ethics Committee of Seiyo Municipal Nomura Hospital.
Ultrasound image analysis
An ultrasonograph (Hitachi EUB-565 or Aloka SSD-2000) equipped with a 7.5 MHz linear type B-mode probe was used by a specialist in ultrasonography to evaluate sclerotic lesions of the common carotid arteries on the day closest to the day of blood biochemistry analysis (within 2 days). Patients were asked to lie supine, and both carotid arteries were observed obliquely from the anterior and posterior directions. We measured the common carotid intima-media thickness (IMT) on the far wall of the bilateral common carotid arteries about 10 mm proximal to the bifurcation on the B-mode monitor, and used the mean values for study. We defined carotid atherosclerosis as IMT measuring 1.1 mm or greater (6).
Other various risk factors
We measured blood pressure in the right upper arm of patients in a seated position using a standard sphygmomanometer. We defined a smoker as a subject with a pack-years index > 0 (pack-years was defined as packs of cigarettes per day multiplied by years smoked). TC, TG, HDL-C and uric acid (UA) were measured within 24 hours after admission while the patient was fasting. The LDL-C level was calculated using the Friedewald formula (7), and patients with TG levels ≥ 400 mg/dl were excluded. History of taking anti-hypertensive and antilipidemic drugs was also evaluated. Diabetes mellitus was defined as any history of treatment for diabetes mellitus.
Statistical analysis
All values are expressed as the mean ± standard deviation (SD), unless otherwise specified. Statistical analysis was performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). In the univariate analysis, unpaired t and chi-square tests were used to compare clinical characteristics in subjects with and without carotid atherosclerosis. A multiple linear regression analysis was employed to evaluate the significant contribution of a risk factor for carotid IMT. Then, to assess the linearity of the association between lipid levels and carotid atherosclerosis, and for ease of interpretation and presentation, lipids were grouped into three categories based on their tertiles. The relation between carotid atherosclerosis and each lipid level was examined by logistic multiple regression analysis. A value of p < 0.05 was considered significant.
Results
Background factors of subjects with and without carotid atherosclerosis by gender
Gender distribution of the total 921 subjects (mean age ± SD, 77 ± 7 years) was 387 males (76 ± 7 years) and 534 females (78 ± 8 years). Four subjects with TG levels ≥ 400 mg/dl were excluded. Of the subjects, 459 received anti-hypertensive drugs, 37 received anti-lipidemic drugs, and 196 diabetic patients had been treated with drugs or diets. Those who had a history of transient ischemic attack or cerebral infarction (n = 321), and angina pectoris or myocardial infarction (n = 77) were included in the study (Table 1) . Table 2 shows background factors of subjects with and without carotid atherosclerosis by gender. In men, smoking status, systolic blood pressure (SBP), TC, LDL-C, non-HDL-C, ratio of TC/HDL-C, prevalence of anti-lipidemic drug use, UA and history of atherosclerotic disease were significantly higher in patients with carotid atherosclerosis than those without carotid atherosclerosis. There were no differences in age, body mass index (BMI), diastolic blood pressure (DBP), prevalence of anti-hypertensive drug use, TG, HDL-C and history of diabetes mellitus between the two groups. In women, age, SBP, prevalence of anti-hypertensive drug use, TC, LDL-C, non-HDL-C, ratio of TC/HDL-C, UA, history of diabetes mellitus, and history of atherosclerotic disease were significantly higher in patients with carotid atherosclerosis than those without carotid atherosclerosis. There were no differences in BMI, smoking status, DBP, TG, HDL-C and prevalence of anti-lipidemic drug use between the two groups.
Multivariate linear regression analysis for intimamedia thickness with conventional risk factors by gender
Multiple linear regression analysis for IMT was performed with risk factors in these subjects (Table 3 ). It was shown that age, smoking status, SBP, TC, HDL-C and UA were significantly associated with IMT in men, and age, SBP, TC, HDL-C and UA in women.
Adjusted odds ratios for carotid atherosclerosis by each lipid level and gender
In men, an increased risk for carotid atherosclerosis was Similarly, in women, an increased risk for carotid atherosclerosis was also positively and linearly associated with increasing levels of TC, LDL-C, and non-HDL-C and ratio of total/HDL-C (Table 4) .
Discussion
This study examined the relation between lipid levels and carotid atherosclerosis evaluated by ultrasonography in elderly patients with risk factors. We demonstrated that the non-HDL-C level was a significant predictor of IMT thickening after adjustment for conventional risk factors including sex, age, SBP, DBP, prevalence of antihypertensive and anti-lipidemic drug use, UA and history of diabetes mellitus in both elderly men and women. Although the confidence intervaIs were overlapping, odds ratios for non-HDL-C were higher than those for either TC or TG alone. Non-HDL-C includes all apolipoprotein B-containing lipoproteins, which is a marker of the sum of VLDL remnant (8), IDL, LDL (9) and lipoprotein (a) (10) particles and considered to be potentially atherogenic. Remnant TG-rich lipoproteins can be taken up by macrophages, leading to increased foam cell formation and accelerated atherosclerosis (2) . Particularly atherogenic forms of LDL include small, dense LDL particles and oxidized LDL (9). An elevation of VLDL is also associated with increases in prothrombotic and procoagulant factors (11) . All lipoproteins that contain apolipoprotein B tend to promote atherosclerosis (12, 13) .
Several studies in populations with and without cardiovascular disease (CVD) have recently been published that document the prognostic utility of non-HDL-C levels. In a Finish cohort study of 787 men aged 31 to 61 years, the probability of 24-year coronary death was not significantly related to HDL-C but was significantly related, positively, to the non-HDL-C concentration (14) . In an Italian occupational cohort of 3,395 men aged 46-65 years, non-HDL-C and blood glucose were found to be predictors of coronary death in a 10-year follow-up (15) . A report from the Lipid Research Clinics Program Follow-up Study suggested that the non-HDL-C level is a somewhat better predictor of CVD mortality than the LDL-C level, and screening for non-HDL-C levels might be useful for CVD risk assessment (3). The British Regional Heart Study also suggested that non-HDL-C in 7,415 men aged 40 to 59 years was a more powerful independent predictor of risk for coronary heart disease (CHD) than the ratio of total/HDL-C (16). These participants were all middle aged. However, the cholesterol-health relationship in old age has been controversial, with several studies reporting an inverse association between cholesterol and mortality.
The Rancho Bernardo Study of 1,386 women and 1,094 men (mean age, 69 years) found that non-HDL-C was not superior to individual lipids, lipoproteins, or their ratios in the prediction of fatal CHD and CVD in a 10 year follow-up (17) . However, Karlamangla et al. (18) reported that increases in serum non-HDL-C might be beneficial in a cohort of high-functioning older persons. Moreover, in the Systolic Hypertension in the Elderly Program, the non-HDL-C level contributed independently to the risk for CHD in a select population 60 years or older (19) . Our study also demonstrated a positive linear association between non-HDL-C levels and carotid atherosclerosis in elderly patients, and non-HDL-C was superior to individual lipids, lipoproteins, or their ratios. Low levels of HDL-C also have been associated with an increased risk for atherosclerosis. Our study suggested similar results for HDL-C in a multiple linear regression analysis employed to evaluate the risk factors for carotid IMT. However, adjusted odds ratios of HDL-C for carotid atherosclerosis defined as IMT ≥ 1.1 mm were not significant. The clinical value of non-HDL-C for risk assessment in the elderly is suggested. To our knowledge, few previously reported studies have examined the relationship between non-HDL-C levels and carotid IMT in the elderly.
Measuring the non-HDL-C level is easy compared with measuring the LDL-C level and is a practical risk assessment tool (3) . Assessment of the LDL-C level using the Friedewald formula is not easy because it requires the measurement of three lipid levels in a fasted blood sample (TC, HDL-C and TG). In contrast, the non-HDL-C level is simply defined as the difference between T-C and HDL-C levels. Non-HDL-C in the non fasting state is more stable than TG and has several practical advantages such as its ability to be measured in patients with TG levels > 400 mg/dl (1) . Therefore, the non-HDL-C rather than LDL-C level may be particularly useful to clinicians who assess and treat elderly patients as an easily measured composite indicator, even though this variable could be affected by dietary patterns and metabolic variables (4) . We need to be aware of the limitations in interpreting the present results. Since all participants were hospitalized patients, we could not eliminate the possible effect of underlying diseases on the results. We also could not eliminate the possible effect of mediation on the present findings. These points need to be addressed again in a large population-based sample in a prospective fashion.
In summary, our results indicate that the non-HDL-C level as well as LDL-C level has a strong linear relationship with carotid atherosclerosis in elderly patients. These data suggest that measurement of the non-HDL-C level rather than LDL-C level should be recommended as a tool for risk and treatment assessments.
